Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geneviève Favre

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|March 12, 2020
[Chronic myeloid leukemia - update 2020]Dominik Heim, Monika Ebnöther, Geneviève Favre
Praxis|April 13, 2022
[Acquired Stomatocytosis in Hyperosmolar Hyperglycemic Derangement]Jan Bur, Geneviève Favre, Annekathrin Mehlig, et al.
Annals of Hematology|September 2, 2004
Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemiaRomaine Viollier, Jakob Passweg, Michael Gregor, et al.
Haematologica|December 9, 2008
Severe events in donors after allogeneic hematopoietic stem cell donationJoerg Halter, Yoshihisa Kodera, Alvaro Urbano Ispizua, et al.
Journal of Clinical Lipidology|January 10, 2018
Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up dataMelanie Premstaller, Melanie Perren, Kuebra Koçack, et al.
British Journal of Haematology|September 22, 2023
Immunomodulation with romiplostim as a second-line strategy in primary immune thrombocytopenia: The iROM studyAlexandra Schifferli, Axel Rüfer, Alicia Rovo, et al.
Haematologica|November 10, 2018
The sympathomimetic agonist mirabegron did not lower <i>JAK2</i>-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14Beatrice Drexler, Jakob R Passweg, Alexandar Tzankov, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|March 12, 2020
[Chronic myeloid leukemia - update 2020]Dominik Heim, Monika Ebnöther, Geneviève Favre
Praxis|April 13, 2022
[Acquired Stomatocytosis in Hyperosmolar Hyperglycemic Derangement]Jan Bur, Geneviève Favre, Annekathrin Mehlig, et al.
Annals of Hematology|September 2, 2004
Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemiaRomaine Viollier, Jakob Passweg, Michael Gregor, et al.
Haematologica|December 9, 2008
Severe events in donors after allogeneic hematopoietic stem cell donationJoerg Halter, Yoshihisa Kodera, Alvaro Urbano Ispizua, et al.
Journal of Clinical Lipidology|January 10, 2018
Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up dataMelanie Premstaller, Melanie Perren, Kuebra Koçack, et al.
British Journal of Haematology|September 22, 2023
Immunomodulation with romiplostim as a second-line strategy in primary immune thrombocytopenia: The iROM studyAlexandra Schifferli, Axel Rüfer, Alicia Rovo, et al.
Haematologica|November 10, 2018
The sympathomimetic agonist mirabegron did not lower <i>JAK2</i>-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14Beatrice Drexler, Jakob R Passweg, Alexandar Tzankov, et al.
Pageof 1